|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
549,884 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,489,672 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
797,417 |
|
|
Total
Value |
$65,428,521 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
Percentage
Gain/Loss : |
-78.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2024-06-12 |
18,323 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-08-16 |
16,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
855 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 15 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-08-15 |
4 |
AS |
$95.21 |
$285,630 |
D/D |
(3,000) |
328,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-10-14 |
4 |
AS |
$89.89 |
$359,560 |
D/D |
(4,000) |
324,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-01-13 |
4 |
AS |
$112.25 |
$1,122,500 |
D/D |
(10,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-01-17 |
4 |
AS |
$111.55 |
$1,115,500 |
D/D |
(10,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-10 |
4 |
AS |
$110.11 |
$1,651,650 |
D/D |
(15,000) |
320,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-13 |
4 |
AS |
$109.15 |
$654,900 |
D/D |
(6,000) |
320,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-10 |
4 |
AS |
$92.28 |
$1,384,200 |
D/D |
(15,000) |
487,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-13 |
4 |
AS |
$90.45 |
$723,600 |
D/D |
(8,000) |
487,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-06 |
4 |
AS |
$96.13 |
$961,300 |
D/D |
(10,000) |
425,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-10 |
4 |
AS |
$99.56 |
$995,600 |
D/D |
(10,000) |
425,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-09 |
4 |
AS |
$94.22 |
$2,847,973 |
D/D |
(30,000) |
426,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-10 |
4 |
AS |
$94.65 |
$2,845,397 |
D/D |
(30,000) |
426,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-05-11 |
4 |
AS |
$94.55 |
$2,840,226 |
D/D |
(30,000) |
426,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2023-12-21 |
4 |
AS |
$93.99 |
$939,900 |
D/D |
(10,000) |
425,112 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-09 |
4 |
AS |
$98.19 |
$981,900 |
D/D |
(10,000) |
425,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-10 |
4 |
AS |
$96.38 |
$963,800 |
D/D |
(10,000) |
425,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
AS |
$89.77 |
$1,346,550 |
D/D |
(15,000) |
419,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-09 |
4 |
AS |
$88.28 |
$1,324,200 |
D/D |
(15,000) |
419,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-11 |
4 |
AS |
$90.99 |
$1,819,800 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-12 |
4 |
AS |
$91.26 |
$1,825,200 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-09 |
4 |
AS |
$81.62 |
$1,632,400 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-10 |
4 |
AS |
$81.14 |
$1,622,800 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2001-04-23 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
8,333 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-12 |
4 |
B |
$10.21 |
$10,208 |
D/D |
1,000 |
11,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2006-01-03 |
4 |
B |
$10.76 |
$16,190 |
D/D |
1,500 |
12,500 |
2.81 |
- |
|
855 Records found
|
|
Page 15 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|